Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.
Kershaw MH, Jackson JT, Haynes NM, Teng MW, Moeller M, Hayakawa Y, Street SE, Cameron R, Tanner JE, Trapani JA, Smyth MJ, Darcy PK.
Kershaw MH, et al. Among authors: teng mw.
J Immunol. 2004 Aug 1;173(3):2143-50. doi: 10.4049/jimmunol.173.3.2143.
J Immunol. 2004.
PMID: 15265951